Original paper
4006 POSTER Gene profile predicts protection from radio-induced late rectal bleeding in prostate cancer
Abstract
Sunitinib, pazopanib, sorafenib, axitinib and bevacizumab are the five recommended antiangiogenic agents in first-line therapy for metastatic renal cell carcinoma (mRCC). Because these drugs underwent simultaneous clinical development, no direct efficacy and safety comparison was ever conducted, thus preventing optimal therapy choices.We performed a traditional and network meta-analysis to evaluate the efficacy and safety of mRCC-recommended...
Paper Details
Title
4006 POSTER Gene profile predicts protection from radio-induced late rectal bleeding in prostate cancer
Published Date
Sep 1, 2007
Volume
5
Issue
4
Pages
281 - 281
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History